COMMUNIQUÉS West-GlobeNewswire

National Research Corporation Declares Quarterly Dividend
21/02/2018
Lincoln, Nebraska, Feb. 20, 2018 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ:NRCIA and NRCIB) today announced that its Board of Directors has declared a quarterly cash dividend of $0.10 (ten cents) per [...]
Portola Pharmaceuticals Announces Results of CHMP Oral Explanations for Andexanet Alfa and Betrixaban
20/02/2018
SOUTH SAN FRANCISCO, Calif., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (Nasdaq: PTLA ) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines [...]
Amarin to Report Fourth Quarter and Full Year 2017 Results and Host Conference Call on February 27th, 2018
20/02/2018
BEDMINSTER, N.J. and DUBLIN, Ireland, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN ), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve [...]
AIT Therapeutics Appoints Two Senior Executives in Research and Clinical Operations
20/02/2018
Mark Rimkus Appointed VP of Clinical Affairs and Dr. Abdi Ghaffari Appointed VP of Research Appointments Add Decades of Nitric Oxide Experience to Team NEW YORK, Feb. 20, 2018 (GLOBE NEWSWIRE) -- AIT Therapeutics Inc. ( [...]
Spring Bank Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full-Year 2017 Financial and Operational Results
20/02/2018
2017 highlighted by continued progress with global inarigivir clinical program for the treatment of chronic HBV and advancement of next-generation STING agonist candidate, SB 11285, towards the clinic Multiple potential [...]
Inovalon Reports Fourth Quarter and Full Year 2017 Results
20/02/2018
Fourth Quarter 2017 Highlights Fourth quarter revenue of $114.6 million, up 19% year-over-year Fourth quarter net income of $17.4 million, resulting in diluted net income of $0.12 per share, inclusive of a one-time [...]
Dova Pharmaceuticals, Inc. Announces Proposed Offering of Common Stock
20/02/2018
DURHAM, N.C., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA ), a pharmaceutical company focused on acquiring, developing and commercializing drug candidates for rare diseases where there is [...]
Quotient Limited Announces the Sale and Leaseback of its Edinburgh, Scotland Manufacturing and R&D Facility
20/02/2018
JERSEY, Channel Islands, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT ), a commercial-stage diagnostics company, today announced it has entered into definitive agreements for the sale and leaseback [...]
Ultragenyx Reports Fourth Quarter and Full Year 2017 Financial Results and Corporate Update
20/02/2018
NOVATO, Calif., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE ), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today reported [...]
Avid Bioservices Announces Closing of Public Offering of Common Stock
20/02/2018
TUSTIN, Calif., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO ) (NASDAQ: CDMOP ) today announced the closing of its previously announced underwritten public offering of 10,294,445 shares of its [...]
HealthEquity to Present at Investor Conferences
20/02/2018
DRAPER, Utah, Feb. 20, 2018 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY ), the largest HSA non-bank custodian, today announced that it plans to participate at the following upcoming investor conferences: BTIG 5 [...]
Peter Miller Named Frank Baldino Bioscience CEO of the Year by Life Sciences Pennsylvania
20/02/2018
YARDLEY, Pa., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Optinose (NASDAQ: OPTN ), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that CEO Peter Miller [...]
Consumer Engagement, Smarter Care Highlight Cerner Presence in Booth 1832 at HIMSS18
20/02/2018
KANSAS CITY, Mo., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Cerner, a global leader in health care technology, will demonstrate its focus on the health care consumer experience and creating smarter and more efficient health [...]
Tetraphase Pharmaceuticals Enters into Exclusive Development and Commercialization Agreement with Everest Medicines for Eravacycline in China
20/02/2018
WATERTOWN, Mass., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ: TTPH ), a biopharmaceutical company focused on developing and commercializing novel antibiotics to treat life-threatening [...]
Ascendis Pharma A/S Announces Proposed Public Offering of ADSs
20/02/2018
COPENHAGEN, Denmark, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND ), a clinical stage biopharmaceutical company, today announced that it has commenced an underwritten public offering of $150,000, [...]
I-MED Pharma's I-PEN® Does Not Infringe the TearLab Patent
20/02/2018
MONTREAL, Feb. 20, 2018 (GLOBE NEWSWIRE) -- On February 14 th TearLab issued a press release indicating it will appeal after its defeat in a patent infringement action against I-MED Pharma Inc. in Canada. In the press [...]
Adventist Health Selects Andrew Jahn to Lead Southern California Region as President
20/02/2018
ROSEVILLE, Calif., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Adventist Health —a faith-based, nonprofit integrated health system serving more than 75 communities in California, Oregon and Hawaii—today announced the appointment [...]
Alavida Health Warns of the Link Between Retirement and Problem Drinking
20/02/2018
VANCOUVER, British Columbia, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Baby boomers—the generation ages 50-69—now account for 23 percent of the American population—a figure that has doubled since the 1970’s. As many of them [...]
Abattis Announces CannaNUMUS Achievement of Second Milestone
20/02/2018
VANCOUVER, British Columbia, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp. (the " Company " or " Abattis ") (CSE:ATT) (OTC:ATTBF) is pleased to announce that CannaNUMUS Blockchain Inc. (" CannaNUMUS "), a [...]

Pages